Study on Delayed Graft Function Using Paired Kidneys
Status:
Unknown status
Trial end date:
2016-05-01
Target enrollment:
Participant gender:
Summary
The study is designed to evaluate the safety and efficacy of an intravenously administered
drug in recipients of kidneys from cardiac death donors who are risk for developing delayed
graft function.
Phase:
Phase 2
Details
Lead Sponsor:
Angion Biomedica Corp
Collaborator:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)